Gastroparesis Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Gastroparesis Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class Type (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)
Publication Month: Jan 2021 | Report Code: TIPRE00008992 | No. of Pages: 155 | Category: Pharmaceuticals | Status: Published
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Gastroparesis Market – By Type
1.3.2 Global Gastroparesis Market – By Drug Class Type
1.3.3 Global Gastroparesis Market – By Distribution Channel
1.3.4 Global Gastroparesis Market – By Geography
2. Gastroparesis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Gastroparesis Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South and Central America- PEST Analysis
4.3 Expert Opinion
5. Gastroparesis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Diabetes Mellitus Prevalence
5.1.2 Increasing Geriatric Population
5.2 Market Restraints
5.2.1 Side Effects of Gastroparesis Drugs
5.3 Market Opportunities
5.3.1 Surging Investments and Financial Assistance for Research
5.4 Future Trends
5.4.1 Emphasis on Gastric Electrical Stimulation Therapy Research
5.5 Impact Analysis
6. Gastroparesis Market – Global Analysis
6.1 Global Gastroparesis Market Revenue Forecast And Analysis
6.2 Global Gastroparesis Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Gastroparesis Market Analysis – By Type
7.1 Overview
7.2 Gastroparesis Market Revenue Share, by Type (2019 and 2027)
7.3 Idiopathic
7.3.1 Overview
7.3.2 Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Diabetic
7.4.1 Overview
7.4.2 Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Post-Surgical
7.5.1 Overview
7.5.2 Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8. Gastroparesis Market Analysis – By Drug Class Type
8.1 Overview
8.2 Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)
8.3 Prokinetic Agents
8.3.1 Overview
8.3.2 Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Botulinum Toxin Injection
8.4.1 Overview
8.4.2 Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Antiemetic Agents
8.5.1 Overview
8.5.2 Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9. Gastroparesis Market Analysis – By Distribution Channel
9.1 Overview
9.2 Gastroparesis Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Retail Pharmacies
9.3.1 Overview
9.3.2 Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
10. Gastroparesis Market – Geographic Analysis
10.1 North America: Gastroparesis Market
10.1.1 Overview
10.1.2 North America: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Gastroparesis Market, by Country, 2019 & 2027 (%)
10.1.7 US: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Gastroparesis Market
10.2.1 Overview
10.2.2 Europe: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 UK Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 UK Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.2.12 Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.1 Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.2 Rest of Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.2.12.3 Rest of Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.2.12.4 Rest of Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Gastroparesis Market
10.3.1 Overview
10.3.2 Asia Pacific: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia Pacific Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.3.4.1 Asia Pacific Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia Pacific: Gastroparesis Market, by Country, 2019 & 2027 (%)
10.3.6 China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.6.1 China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.6.2 China Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.6.3 China Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.3.6.3.1 China Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.7 Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 Japan Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.7.3 Japan Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.3.7.3.1 Japan Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.8 India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 India Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.8.3 India Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.3.8.4 India Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.9 South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 South Korea Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.9.3 South Korea Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.3.9.4 South Korea Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.10 Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 Australia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.10.3 Australia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.3.10.4 Australia Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.11 Rest of Asia Pacific: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Rest of Asia Pacific: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Rest of Asia Pacific Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Rest of Asia Pacific Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Rest of Asia Pacific Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Gastroparesis Market
10.4.1 Overview
10.4.2 Middle East & Africa: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Gastroparesis Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.4.9.4 South Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.4.9.5 Rest of Middle East and Africa: Gastroparesis Market - Revenue and Forecasts to 2027 (USD Million)
10.4.9.5.1 Rest of Middle East and Africa: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)
10.4.9.6 Rest of Middle East and Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.9.7 Rest of Middle East and Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.4.9.8 Rest of Middle East and Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Gastroparesis Market
10.5.1 Overview
10.5.2 South and Central America: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Gastroparesis Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.5.8.5 Rest of South and Central America: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)
10.5.8.5.1 Rest of South and Central America: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)
10.5.8.6 Rest of South and Central America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.7 Rest of South and Central America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.8 Rest of South and Central America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Gastroparesis Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Gastroparesis Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Gastroparesis Market, 2018-2020
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Evoke Pharma
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Allergan Plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 NEUROGASTRX, INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bausch Health Companies Inc.( Salix Pharmaceuticals)
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Pfizer Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ANI Pharmaceuticals, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Ipca Laboratories Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 CinRx Pharma, LLC (CinDome Pharma)
13.10.1 Business Description
13.10.2 Products and Services
13.10.3 Financial Overview
13.10.4 SWOT Analysis
13.10.5 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Gastroparesis Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Gastroparesis Market, by Drug Class Type– Revenue and Forecast to 2027 (USD Million)
Table 3. North America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 4. US Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. US Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 6. US Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 13. Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 16. Germany Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Germany Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 19. UK Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 20. UK Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 21. UK Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 22. France Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. France Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 24. France Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 25. Spain Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. Spain Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 27. Spain Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 28. Italy Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Italy Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 30. Italy Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 31. Rest of Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 32. Rest of Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 33. Rest of Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 34. Asia Pacific Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Asia Pacific Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Asia Pacific Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 37. China Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 38. China Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 39. China Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 40. Japan Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 41. Japan Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 42. Japan Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 43. India Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 44. India Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 45. India Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 46. South Korea Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 47. South Korea Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 48. South Korea Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 49. Australia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 50. Australia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 51. Australia Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 52. Rest of Asia Pacific Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of Asia Pacific Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of Asia Pacific Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 55. Middle East & Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 56. Middle East & Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 57. Middle East & Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 58. Saudi Arabia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 59. Saudi Arabia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 60. Saudi Arabia Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 61. UAE Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 62. UAE Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 63. UAE Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 64. South Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 65. South Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 66. South Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 67. Rest of Middle East and Africa Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 68. Rest of Middle East and Africa Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 69. Rest of Middle East and Africa Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 70. South and Central America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 71. South and Central America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 72. South and Central America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 73. Brazil Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 74. Brazil Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 75. Brazil Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 76. Argentina Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 77. Argentina Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 78. Argentina Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 79. Rest of South and Central America Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 80. Rest of South and Central America Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 81. Rest of South and Central America Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 82. Recent Inorganic Growth Strategies in the Gastroparesis market
Table 83. Recent Organic Growth Strategies In the Gastroparesis market
Table 84. Glossary of Terms, Gastroparesis Market
LIST OF FIGURES
Figure 1. Gastroparesis Market Segmentation
Figure 2. Gastroparesis Market Segmentation, By Region
Figure 3. Gastroparesis Market Overview
Figure 4. Idiopathic Segment Held Largest Share of Gastroparesis Market
Figure 5. APAC to Show Remarkable Growth During Forecast Period
Figure 6. Gastroparesis Market, by Geography (US$ Million)
Figure 7. Global Gastroparesis Market – Leading Country Markets (US$ Million)
Figure 8. Global Gastroparesis Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Gastroparesis Market Impact Analysis of Drivers and Restraints
Figure 15. Global Gastroparesis Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Gastroparesis Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Gastroparesis Market
Figure 18. Gastroparesis Market Revenue Share, by Type (2019 and 2027)
Figure 19. Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)
Figure 24. Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Gastroparesis Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 28. Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. North America: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. North America Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 33. North America: Gastroparesis Market, by Country, 2019 & 2027 (%)
Figure 34. US: Pharmaceutical Drug Delivery market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Canada: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Mexico: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Europe: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)
Figure 38. Europe Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)
Figure 40. Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Asia Pacific: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)
Figure 47. Asia Pacific Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 48. China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Rest of Asia Pacific: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Middle East & Africa: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)
Figure 55. Middle East & Africa Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 56. Middle East & Africa: Gastroparesis Market, by Country, 2019 & 2027 (%)
Figure 57. Saudi Arabia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. UAE: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. South Africa: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. Rest of Middle East and Africa: Gastroparesis Market- Revenue And Forecasts To 2027 (USD Million)
Figure 61. South and Central America: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)
Figure 62. South and Central America Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Gastroparesis Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. Argentina: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 66. Rest of South and Central America: Gastroparesis Market- Revenue And Forecasts To 2027 (USD Million)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic in European Country Markets
Figure 69. Impact of COVID-19 Pandemic on Gastroparesis Market in Asia Pacific Countries
Figure 70. Impact Of COVID-19 Pandemic in Middle East and Africa Market
Figure 71. Impact Of COVID-19 Pandemic in South and Central America Market
Figure 72. Growth Strategies in the Gastroparesis Market, 2018-2020
The List of Companies - Gastroparesis Market
- EVOKE PHARMA
- Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
- Johnson and Johnson Services, Inc.
- Allergan Plc
- NEUROGASTRX, INC.
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Pfizer Inc.
- ANI Pharmaceuticals, Inc.
- Ipca Laboratories Ltd.
- Cinrx Pharma, LLC (Cindome Pharma)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the gastroparesis market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global gastroparesis market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount